ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ADVM Adverum Biotechnologies Inc

10.43
0.43 (4.30%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Adverum Biotechnologies Inc ADVM NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.43 4.30% 10.43 13:00:01
始値 安値 高値 終値 前日終値
10.10 10.00 10.69 10.43 10.00
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0321:00GLOBEAdverum Biotechnologies to Participate in Upcoming May..
2024/4/2605:05GLOBEAdverum Biotechnologies to Present LUNA 26-week Phase 2..
2024/3/1905:05GLOBEAdverum Biotechnologies Reports Fourth Quarter and Full Year..
2024/3/0506:40EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/2/2906:05GLOBEAdverum Biotechnologies to Participate in the TD Cowen 44th..
2024/2/2305:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/2205:39EDGAR2Form D - Notice of Exempt Offering of Securities
2024/2/1606:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1510:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1506:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1222:00GLOBEAdverum Biotechnologies to Participate in the Oppenheimer..
2024/2/1007:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1001:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0822:45EDGAR2Form 8-K - Current report
2024/2/0821:00GLOBEAdverum Biotechnologies Announces Positive Preliminary..
2024/2/0706:47EDGAR2Form 8-K - Current report
2024/2/0607:03EDGAR2Form 8-K - Current report
2024/2/0521:45GLOBEAdverum Biotechnologies Announces $127.5 Million Private..
2024/2/0207:30GLOBEAdverum Biotechnologies will Host Webcast to Review LUNA..
2024/1/2922:00GLOBEAdverum Biotechnologies Appoints Romuald Corbau, Ph.D. as..
2023/12/0906:11EDGAR2Form 8-K - Current report
2023/12/0806:05GLOBEAdverum Biotechnologies to Present LUNA Preliminary Efficacy..
2023/12/0506:09EDGAR2Form 8-K/A - Current report: [Amend]
2023/11/2906:05GLOBEAdverum Biotechnologies to Participate in the Evercore ISI..
2023/11/1006:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:07EDGAR2Form 8-K - Current report
2023/11/1006:05GLOBEAdverum Biotechnologies Reports Third Quarter 2023 Financial..
2023/11/0709:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0709:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/0706:10EDGAR2Form 8-K - Current report
2023/11/0622:00GLOBEAdverum Biotechnologies Appoints C. David Nicholson, Ph.D...
2023/11/0506:54GLOBEAdverum Biotechnologies Announces 3-Year Efficacy and Safety..
2023/9/2705:05GLOBEAdverum Biotechnologies Announces Positive Aflibercept..
2023/9/2205:05GLOBEAdverum Biotechnologies to Participate in Upcoming Investor..
2023/9/1907:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0605:05GLOBEAdverum Biotechnologies to Participate in the H.C...
2023/8/2205:05GLOBEAdverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as..
2023/8/1421:00GLOBEAdverum Biotechnologies to Participate in the H.C...
2023/8/1105:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:09EDGAR2Form 8-K - Current report
2023/8/1105:05GLOBEAdverum Biotechnologies Completes Enrollment of Phase 2 LUNA..
2023/8/0505:18EDGAR2Form 8-K - Current report
2023/7/2505:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/6/1221:00GLOBEAdverum Biotechnologies Grants License to Ray Therapeutics..
2023/6/0221:00GLOBEAdverum Biotechnologies to Participate in the Jefferies..
2023/5/2519:30GLOBEAdverum Biotechnologies Announces New Executive Leadership..
2023/5/1822:00GLOBEAdverum Biotechnologies Introduces an Intravitreal Gene..

最近閲覧した銘柄

Delayed Upgrade Clock